Restricted
Tier 4
Infusion site reactions
N/V/D
Xerava
Distribution: Vdss: ~321 L (~4 L/kg)
Protein binding: 79% to 90% (increases with increasing plasma concentrations)
Metabolism: Primarily by CYP3A4- and FMO-mediated oxidation
Half-life elimination: 20 hours
Excretion: Urine: ~34% (20% as unchanged drug); Feces: 47% (17% as unchanged drug)